000 01390 a2200385 4500
005 20250517061833.0
264 0 _c20160920
008 201609s 0 0 eng d
022 _a1878-1705
024 7 _a10.1016/j.intimp.2015.10.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKang, Moo Rim
245 0 0 _aCardiovascular protective effect of glabridin: Implications in LDL oxidation and inflammation.
_h[electronic resource]
260 _bInternational immunopharmacology
_cDec 2015
300 _a914-918 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xpharmacology
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aCardiotonic Agents
_xpharmacology
650 0 4 _aHumans
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aIsoflavones
_xpharmacology
650 0 4 _aLipoproteins, LDL
_xdrug effects
650 0 4 _aPhenols
_xpharmacology
700 1 _aPark, Ki Hwan
700 1 _aOh, Soo Jin
700 1 _aYun, Jieun
700 1 _aLee, Chang Woo
700 1 _aLee, Myeong Youl
700 1 _aHan, Sang-Bae
700 1 _aKang, Jong Soon
773 0 _tInternational immunopharmacology
_gvol. 29
_gno. 2
_gp. 914-918
856 4 0 _uhttps://doi.org/10.1016/j.intimp.2015.10.020
_zAvailable from publisher's website
999 _c25411239
_d25411239